128 results
Page 4 of 7
8-K
EX-99.1
1r4uatk
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
EX-99.1
hlktsc1xrb6qi9dc
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
jiwa6wjg wenb8h8
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
3wn5ln06xrseacmd
6 Jan 20
Fibrogen Names Enrique Conterno As Chief Executive Officer
5:23pm
8-K
EX-99.1
kt5lzxd07wbp4w06kvdb
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
8-K
EX-99.1
bhz4whfmun6x
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.1
b78ywbztb
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.2
ajm0yg7nat
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
korzo4061j ftflhsp5i
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
66v cb8nw77s4
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
0uy55 jzcz
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
rpcl 8fl37al
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
nry7l3gi
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
jid3b9xegg4dbxu0m9
26 Aug 19
Departure of Directors or Certain Officers
9:04am
8-K
EX-99.1
yzv9wz
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm
8-K
EX-99.1
wguig xun8w8iqb1xguv
8 Aug 19
Fibrogen Reports Second Quarter 2019 Financial Results
4:15pm
8-K
EX-99.1
xn6vfdfp b2kohg
24 Jul 19
Other Events
9:46pm
8-K
EX-99.2
rl6rpvz480a4a ddg8
24 Jul 19
Other Events
9:46pm